ArticleFrontiers in endocrinology2022

SGLT2 inhibitor treatment is not associated with an increased risk of osteoporotic fractures when compared to GLP-1 receptor agonists: A nationwide cohort study.

Zheer Kejlberg Al-Mashhadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.